Clinical analysis of 76 cases of erlotinib-induced skin rash in the treatment of non-small cell lung cancer

作者
Caicun Zhou
出处
期刊:Tumori
摘要

Objective:To evaluate the relationship between erlotinib-induced skin rash and clinical outcome and explore the effective way to prevent skin rash.Methods:The data from 76 non-small cell lung cancer(NSCLC) patients who experienced erlotinib-induced skin rash from Dec 2005 to Sep 2008 were collected.All the patients were confirmed with NSCLC by pathological and cytological examination and received erlotinib 150 mg/d till they had progressive disease or intolerable adverse reaction.The severity of skin rash was recorded and graded according to National Cancer Institute-Common Toxicity Criteria(NCI-CTC).The therapeutic outcome of skin rash was observed.Results:The skin rash develops as early as 3 days after commencement of erlotinib therapy,with median onset at 8 days.Twenty-seven(35.5%) patients experienced grade 1 skin rash,44 patients(57.9%) had grade 2 and 5 cases(6.6%) had grade 3 skin rash.A statistically significant correlation was observed between skin rash and erlotinib therapy.The disease-controlling rate was 63.0% for grade 1 skin rash patients including 5 cases with partial remission and 12 cases with stable disease and 91.8% for grade 2/3 skin rash patients including 32 cases with partial remission and 13 cases with stable disease(P0.05).The median time to progression(TTP) and median overall survival(OS) were prolonged in patients experienced grade 2/3 skin rash compared with those in patients with grade 1 skin rash(TTP:5.1 months vs 9.7 months,P0.01;OS:10.0 months vs 14.6 months,P0.01).The skin rash was alleviated in 60 out of 76 patients(78.9%).Conclusion:Skin rash is a potent surrogate marker of favorable outcome in patients who received erlotinib treatment.It was tolerable to most patients.Appropriate therapy may be useful in decreasing the severity of skin rash.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
青葙完成签到,获得积分10
1秒前
123456发布了新的文献求助10
2秒前
11NING发布了新的文献求助10
3秒前
Ysk完成签到,获得积分10
3秒前
5秒前
675675发布了新的文献求助10
7秒前
汉堡包的应助被小艾同学采纳,获得10
7秒前
8秒前
11秒前
11NING完成签到,获得积分10
11秒前
11秒前
SCI完成签到,获得积分10
12秒前
Koi发布了新的文献求助10
12秒前
禹hs完成签到,获得积分10
15秒前
吱ing完成签到 ,获得积分10
16秒前
ding的应助被bbb采纳,获得10
16秒前
SCI发布了新的文献求助10
16秒前
ZeSheng完成签到,获得积分10
17秒前
18秒前
18秒前
18秒前
眠龙完成签到 ,获得积分10
19秒前
猪猪侠完成签到,获得积分10
20秒前
20秒前
20秒前
英俊的铭的应助被xxx采纳,获得10
21秒前
水煮电吹风的应助被叶95采纳,获得10
21秒前
ylfs完成签到,获得积分10
21秒前
22秒前
bobo完成签到,获得积分10
23秒前
小艾同学发布了新的文献求助10
23秒前
see发布了新的文献求助10
24秒前
在水一方的应助被LILILILI采纳,获得30
25秒前
嘤嘤嘤完成签到,获得积分10
25秒前
25秒前
999完成签到,获得积分10
25秒前
123完成签到 ,获得积分10
26秒前
香蕉觅云的应助被祥子的骆驼采纳,获得10
27秒前
。。。完成签到,获得积分0
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568